Center for Program Integrity

Dara Corrigan is the Deputy Administrator and Director of the Center for Program Integrity, charged with leading CMS's efforts to prevent fraud and abuse. She recently served as a vice president at Fresenius Kabi, a global health care company. Ms. Corrigan has more than 20 years of government service in health care-related positions, including a tenure as Associate Commissioner for Global Regulatory Policy at the Food and Drug Administration, where she was FDA’s lead negotiator for the Mutual Recognition Agreement with the European Union (EU), allowing the U.S. and EU to eliminate duplicative drug manufacturing inspections. Ms. Corrigan's career also includes drafting regulations under the Affordable Care Act that overhauled the private insurance market, serving as the Acting Inspector General at the Department of Health and Human Services, and practicing law at the Department of Justice for eight years. Combined with her private sector experience, she brings a deep knowledge of health care systems, drug development, safety and quality issues, and private and public payors – a combination that powerfully equips her to coordinate the prevention of fraud and abuse in the Medicare, Medicaid, and CHIP programs. She received her Juris Doctor from the University of Virginia in 1990 and her undergraduate degree from Baylor University.